Homeresearch

research

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026

biotech

Confidence boost for AI virtual cells for novel target discovery

Jim Cornall - October 6, 2026

biotech

Anti-fibrotic drug could be repurposed to control cell communication

Jim Cornall - October 6, 2026

biotech

Positive data from oral therapy designed to improve muscle function and body composition

Jim Cornall - October 5, 2026

photonics

Super photon research could lead to tap-proof communication

Jim Cornall - September 6, 2024

photonics

Lighting the way for quantum innovation

Jim Cornall - August 30, 2024

research

Paving the way for improved fuel cell vehicles

Jim Cornall - August 14, 2024

biotech

European Inventor Award 2024 finalists revealed

Jim Cornall - May 29, 2024

energy

Researchers hail solar cell technology advancement

Jim Cornall - May 15, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

research

New opportunities for 2D material

Jim Cornall - March 15, 2024

research

A “quantum leap” at room temperature

Jim Cornall - February 16, 2024

1...345 Page 4 of 5

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

Jim Cornall - October 6, 2026 0

UTR Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 3′UTRMYCN M1-14 (UTRxMYCN M1-14)...

Confidence boost for AI virtual cells for novel target discovery

biotech Jim Cornall - October 6, 2026 0

Anti-fibrotic drug could be repurposed to control cell communication

biotech Jim Cornall - October 6, 2026 0

Positive data from oral therapy designed to improve muscle function and body composition

biotech Jim Cornall - October 5, 2026 0

Pneumonia can reveal undiagnosed blood cancer

biotech Jim Cornall - October 5, 2026 0